Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cardiac metastases
Tumours metastatic to the heart (cardiac metastases) are among the least known and highly
debated issues in oncology, and few systematic studies are devoted to this topic. Although …
debated issues in oncology, and few systematic studies are devoted to this topic. Although …
Cancer of unknown primary site
GR Varadhachary, MN Raber - New England Journal of Medicine, 2014 - Mass Medical Soc
This review summarizes how sophisticated imaging, immunohistochemical testing, and
molecular-profiling tools are changing the approach to cancer of unknown primary site …
molecular-profiling tools are changing the approach to cancer of unknown primary site …
Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian …
The emerging role of the cancer cell-immune cell interface in sha** tumorigenesis/
anticancer immunotherapy has increased the need to identify prognostic biomarkers …
anticancer immunotherapy has increased the need to identify prognostic biomarkers …
Immunohistochemistry for diagnosis and prognosis of breast cancer: a review
Breast cancer is the most prevalent malignant tumor and main oncologic cause of mortality
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas
The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated
transcription factor and epigenetic regulator, was identified as a tissue type-specific protein …
transcription factor and epigenetic regulator, was identified as a tissue type-specific protein …
Switching benchmarks in cancer of unknown primary: from autopsy to microarray
INTRODUCTION: Cancer of unknown primary (CUP) is associated with unknown biology
and dismal prognosis. Information on the primary site of origin is scant and has never been …
and dismal prognosis. Information on the primary site of origin is scant and has never been …
Carcinoma of unknown primary (CUP)
N Pavlidis, K Fizazi - Critical reviews in oncology/hematology, 2009 - Elsevier
Carcinoma of unknown primary (CUP) is one of the 10 most frequent cancers worldwide. It
constitutes 3–5% of all human malignancies. Patients with CUP present with metastases …
constitutes 3–5% of all human malignancies. Patients with CUP present with metastases …
[HTML][HTML] Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls
Immunohistochemistry is an essential component of diagnostic breast pathology. The
emergence of novel assays and applications is accompanied by new interpretation criteria …
emergence of novel assays and applications is accompanied by new interpretation criteria …
Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples
The histologic subtype of non-small cell lung carcinoma is important in selecting appropriate
chemotherapy for patients with advanced disease. As many of these patients are not …
chemotherapy for patients with advanced disease. As many of these patients are not …
Mesothelin expression in human tumors: a tissue microarray study on 12,679 tumors
S Weidemann, P Gagelmann, N Gorbokon, M Lennartz… - Biomedicines, 2021 - mdpi.com
Mesothelin (MSLN) represents an attractive molecule for targeted cancer therapies. To
identify tumors that might benefit from such therapies, tissue microarrays including 15,050 …
identify tumors that might benefit from such therapies, tissue microarrays including 15,050 …